Ignite Creation Date:
2024-05-06 @ 6:38 PM
Last Modification Date:
2024-10-26 @ 2:52 PM
Study NCT ID:
NCT05739227
Status:
RECRUITING
Last Update Posted:
2023-02-22
First Post:
2023-02-11
Brief Title:
Safety and Efficacy of Allogenic CD19-CAR-NK Cells in Treatmenting rr B-cell Hematologic Malignancies
Sponsor:
Xuzhou Medical University
Organization:
Xuzhou Medical University
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-03-01
Start Date Type:
ESTIMATED
Primary Completion Date:
2025-05
Primary Completion Date Type:
ESTIMATED
Completion Date:
2025-05
Completion Date Type:
ESTIMATED
First Submit Date:
2023-02-11
First Submit QC Date:
February 11 2023
Study First Post Date:
2023-02-22
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-02-11
Last Update Post Date:
2023-02-22
Last Update Post Date Type:
ACTUAL